IGF1 and benign prostatic hyperplasia: It has been shown that lycopene has a role in the prevention and management of BPH mainly through its antioxidant activity, inhibition of cell cycle progression, induction of apoptosis, increasing of gap-junctional cell communication, and inhibition of insulin-like growth factor I signal transduction (9–11).